Using 3D cell culture models and high content confocal imaging to evaluate efficacy and expose toxic liabilities in the drug development pipeline

C.E. Credits: P.A.C.E. CE Florida CE
Speakers
  • Head of Services, Visikol, Inc.
    Biography
      Erin holds a bachelor's degree from Brown University in Biomedical Engineering and a PhD from Georgia Tech in Bioengineering. With a background in topics ranging from immuno-oncology to cell mechanics, Erin has a passion for using advanced cell culture models to study complex disease mechanisms and evaluate new therapeutics. Erin brings over 8 years of in vitro assay development experience to Visikol as the Head of Services, where she focuses on developing and executing assays to help biotech and pharmaceutical Clients study disease, evaluate therapeutics, and mitigate toxicity risks.

    Abstract:

    With an increasing push to improve safety, efficacy, and efficiency throughout the drug development pipeline, researchers are evermore looking to improve the predictive capacity of their in vitro models. By employing 3D cell culture models (i.e. spheroids, organoids), which better recapitulate the native tissue environment in comparison to traditional 2D cultures, disease states can be mimicked more effectively, and thus therapeutics can be evaluated in a more meaningful context. Yet the use of these more complex 3D cell culture models stipulates a more sophisticated method of analysis in order to extract the full potential of these models. In this webinar, Erin Edwards of Visikol will discuss 1) how 3D cell culture models can be designed and applied to evaluate new therapeutics, and 2) how tissue clearing and 3D high content confocal imaging can be used to extract the most meaningful conclusions from studies involving 3D cell culture models. Examples will be given from toxicity evaluation (neural, cardiac, liver) and traditional and immuno-oncology.

    Learning Objectives:
    1. Understand the differences, pros, and cons of each 2D and 3D cell culture models
    2. Learn about specific applications in drug discovery where 3D cell culture models can afford advantages over traditional 2D cell culture models.


    Show Resources
    You May Also Like
    JAN 23, 2020 9:00 AM PST
    C.E. CREDITS
    JAN 23, 2020 9:00 AM PST
    DATE: January 23, 2020 TIME: 9:00am PST, 12:00pm EST...
    SEP 05, 2019 4:00 PM CEST
    C.E. CREDITS
    SEP 05, 2019 4:00 PM CEST
    DATE: September 5, 2019TIME: 7:00am PT, 10:00am ET, 4:00pm CEST PCR (Polymerase Chain Reaction) has gone through a massive evolution since its development in 1983. Besides it...
    OCT 02, 2019 11:00 AM PDT
    OCT 02, 2019 11:00 AM PDT
    DATE: October 2, 2019TIME: 11:00am PDT, 2:00pm EDT Ditch the Excel spreadsheets and manage your molecular workflows entirely in your LIMS Achieve configuration of molecular workf...
    FEB 26, 2020 9:00 AM PST
    C.E. CREDITS
    FEB 26, 2020 9:00 AM PST
    DATE: February 26, 2020 TIME: 9:00am PST 3D cell culture and analysis and the study of organoids and spheroids are becoming more prevalent as a research method in publications as traditional...
    NOV 18, 2019 7:00 AM PST
    C.E. CREDITS
    NOV 18, 2019 7:00 AM PST
    DATE: November 18, 2019TIME: 7:00am PST, 11:00am EST, 4:00pm CEWT How often do you pipette in your cell culture lab every day? Usually, we do it so often that we tend stop th...
    MAR 03, 2020 9:00 AM JST
    Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
    C.E. CREDITS
    MAR 03, 2020 9:00 AM JST
    Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
    DATE: March 3, 2020 TIME: 9:00am JST A major limitation in the ex vivo expansion of harvested human hematopoietic stem-progenitor cells (HSPCs) is the rapid differentiation of HSPCs at the e...
    Loading Comments...
    Show Resources